To estimate the epidemiological value of HSP90AA1-IT1 in the glioma patients, we divided 65 patients with gliomas, consisting of various grades, into two groups according to the relative expression levels of HSP90AA1-IT1. This evidence concerns the gene HSP90AA1 and central nervous system cancer.